Back

Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage

European Heart Journal

9 August 2021
Organised by: Logo
Read full article
ESC Journals VALVULAR, MYOCARDIAL, PERICARDIAL, PULMONARY, CONGENITAL HEART DISEASE Myocardial Disease BASIC SCIENCE

Contributors

Gabriele G Schiattarella
Gabriele G Schiattarella

Author

Charite University Hospital Berlin , Germany

David Bode
David Bode

Author

You may be interested in
thumbnail
Congress Presentation
The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers
27 August 2021
thumbnail
Congress Session
The power of now: a focus on SGLT2 inhibitors for heart failure in the hospital
17 May 2025
thumbnail
Congress Presentation
Characterization of myocardial sodium-glucose cotransporter 1 expression in humans with heart failure and reduced ejection fraction
29 August 2020
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources